SINGER JAMES R 13D/13G Filings for Ovid Therapeutics Inc. (OVID)

SINGER JAMES R 13D and 13G filings for Ovid Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-05
3:12 pm
Purchase
2020-12-31 13G Ovid Therapeutics Inc.
OVID
SINGER JAMES R 3,000,000
4.700%
150,000increase
(+5.26%)
Filing